Trend of new psychoactive substances use in Paris metropolis highlighted by hair testing in a cohort of hospitalized patients

被引:0
|
作者
Larabi, I. A. [1 ]
Abe, E. [1 ]
Etting, I. [1 ]
Martin, M. [1 ]
Dugues, P. [1 ]
Edel, Y. [2 ]
Alvarez, J. C. [1 ]
机构
[1] Versailles Paris Saclay Univ, Raymond Poincare Hosp, AP HP, Dept Pharmacol & Toxicol,INSERM,U1173, 104 Blvd Raymond Poincare, Garches, France
[2] Hop La Pitie Salpetriere, AP HP, Addict Clin, 47-83 Blvd Hop, Paris, France
关键词
hair; new psychoactive substances; Paris; prevalence;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PM1-033
引用
收藏
页码:62 / 63
页数:2
相关论文
共 13 条
  • [1] ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
    Engelgardt, Piotr
    Krzyzanowski, Maciej
    Piotrowski, Przemyslaw
    Borkowska-Sztachanska, Malgorzata
    Wasilewska, Agnieszka
    INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH, 2022, 35 (04) : 485 - 495
  • [2] Use of new psychoactive substances to mimic prescription drugs: The trend in France
    Batisse, Anne
    Eiden, Celine
    Peyriere, Helene
    Djezzar, Samira
    NEUROTOXICOLOGY, 2020, 79 : 20 - 24
  • [3] Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population
    Salomone, Alberto
    Palamar, Joseph J.
    Gerace, Enrico
    Di Corcia, Daniele
    Vincenti, Marco
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2017, 41 (05) : 376 - 381
  • [4] New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
    Alias-Ferri, Maria
    Pellegrini, Manuela
    Marchei, Emilia
    Pacifici, Roberta
    Rotolo, Maria Concetta
    Pichini, Simona
    Perez-Mana, Clara
    Papaseit, Esther
    Muga, Robert
    Fonseca, Francina
    Torrens, Marta
    Farre, Magi
    BIOLOGY-BASEL, 2022, 11 (05):
  • [5] Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
    Grafinger, Katharina Elisabeth
    Liechti, Matthias E.
    Liakoni, Evangelia
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (03) : 429 - 436
  • [6] The Trend Points towards Pure Substances - Changes in the use of "Legal Highs"/New Psychoactive Substances (NPS) Based on the Results of 2 Online Surveys
    Werse, B.
    Morgenstern, C.
    SUCHTTHERAPIE, 2015, 16 (01) : 36 - 41
  • [7] Frequency of new psychoactive substances in hair and urine samples of individuals subject to drug testing in driving license regranting-A toxicological perspective
    Fels, Helena
    Musshoff, Frank
    Graw, Matthias
    DeVol, Don
    Wagner, Thomas
    Holzer, Anna
    DRUG TESTING AND ANALYSIS, 2023, 15 (08) : 919 - 926
  • [8] Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs A cross sectional study by hair testing (2012-2017)
    Larabi, I. A.
    Fabresse, N.
    Etting, I.
    Nadour, L.
    Pfau, G.
    Raphalen, J. H.
    Philippe, P.
    Edel, Y.
    Alvarez, J. C.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [9] Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)
    Institoris, Laszlo
    Kovacs, Katalin
    Sija, Eva
    Berkecz, Robert
    Kormoczi, Timea
    Nemeth, Istvan
    Elek, Istvan
    Bakos, Agnes
    Urban, Ildiko
    Pap, Csaba
    Kereszty, Eva
    CLINICAL TOXICOLOGY, 2022, 60 (01) : 18 - 24
  • [10] Clinical characteristics of patients admitted to emergency department for the use of ketamine analogues with or without other new psychoactive substances
    Weng, Te-, I
    Chin, Lengsu W.
    Chen, Lian-Yu
    Chen, Ju-Yu
    Chen, Guan-Yuan
    Fang, Cheng-Chung
    CLINICAL TOXICOLOGY, 2021, 59 (06) : 528 - 531